What is Vively?
Vively operates a continuous glucose monitoring program integrated with a sophisticated mobile application. This platform delivers real-time insights into how lifestyle factors such as diet, sleep, and exercise influence glucose levels. The service is designed for individuals aiming to understand and manage their metabolic health, including those with insulin resistance, diabetes, or seeking weight management solutions. Vively further enhances its offering with personalized dietitian coaching, making complex health data actionable and accessible without the necessity of expensive medical consultations. The program has already supported over 15,000 members in proactively managing their health.
How much funding has Vively raised?
Vively has raised a total of $1.5M across 1 funding round:
Angel/Seed
$1.5M
Angel/Seed (2022): $1.5M with participation from Archangel Ventures
Key Investors in Vively
Archangel Ventures
Archangel Ventures is a technology-focused investment firm based in London, United Kingdom, known for its diverse portfolio of ventures and commercial businesses.
What's next for Vively?
The substantial enterprise-level funding Vively has received signals a strong market validation and provides the capital necessary for scaling its operations and expanding its technological capabilities. This strategic investment is likely to fuel further development of its continuous glucose monitoring technology and app features, potentially enhancing AI-driven insights and personalization. The company may also look to broaden its reach through strategic partnerships or direct market expansion, aiming to solidify its position as a leader in accessible metabolic health management. Continued focus on dietitian coaching integration will be key to maintaining its unique value proposition.
See full Vively company page
